Sign in

CIK 0000788920 · Non-accelerated filer<br>Smaller reporting company

PRO DEX INC

Sign in to watch
Ticker
PDEX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Entity type
operating
EIN
841261240
Phone
949-769-3231
Business address
2361 MCGAW AVENUE, IRVINE, CA, 92614
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,351,685
in 3 filings, $1.2M under 10b5-1 plans

Net −$1,351,685. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Van Kirk Richard Lee Jr −$1.2M Chief Executive Officer sold 20% of stake
  2. Charlton Alisha −$141K Chief Financial Officer sold 10% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-07 CABILLOT RAYMOND E Director Grant or award · Stock Option (Right-to-buy) +4,000 20,000
2020-12-07 Swenson Nicholas John Director Grant or award · Stock Option (Right-to-buy) +4,000 4,000
2020-12-07 Swenson Nicholas John Director Grant or award · Stock Option (Right-to-buy) +4,000 8,000
2020-12-07 Swenson Nicholas John Director Grant or award · Stock Option (Right-to-buy) +4,000 12,000
2020-12-07 Swenson Nicholas John Director Grant or award · Stock Option (Right-to-buy) +4,000 16,000
2020-12-07 Swenson Nicholas John Director Grant or award · Stock Option (Right-to-buy) +4,000 20,000
2020-12-07 Farrell William James III Director Grant or award · Stock Option (Right-to-buy) +4,000 4,000
2020-12-07 Farrell William James III Director Grant or award · Stock Option (Right-to-buy) +4,000 8,000
2020-12-07 Farrell William James III Director Grant or award · Stock Option (Right-to-buy) +4,000 12,000
2020-12-07 Farrell William James III Director Grant or award · Stock Option (Right-to-buy) +4,000 16,000
2020-12-07 Farrell William James III Director Grant or award · Stock Option (Right-to-buy) +4,000 20,000
2020-12-07 Charlton Alisha Chief Financial Officer Grant or award · Stock Option (Right-to-buy) +4,250 4,250
2020-12-07 Charlton Alisha Chief Financial Officer Grant or award · Stock Option (Right-to-buy) +4,250 8,500
2020-12-07 Charlton Alisha Chief Financial Officer Grant or award · Stock Option (Right-to-buy) +4,250 12,750
2020-12-07 Charlton Alisha Chief Financial Officer Grant or award · Stock Option (Right-to-buy) +4,250 17,000
2020-12-07 Charlton Alisha Chief Financial Officer Grant or award · Stock Option (Right-to-buy) +4,250 21,250
2020-12-07 HOVDA DAVID Director Grant or award · Stock Option (Right-to-buy) +4,000 5,500
2020-12-07 HOVDA DAVID Director Grant or award · Stock Option (Right-to-buy) +4,000 9,500
2020-12-07 HOVDA DAVID Director Grant or award · Stock Option (Right-to-buy) +4,000 13,500
2020-12-07 HOVDA DAVID Director Grant or award · Stock Option (Right-to-buy) +4,000 17,500

Page 8 of 10 · 199 trades